The findings, which appeared today in JAMA Network Open, are strong evidence that buprenorphine, a medication approved by the U.S. Food and Drug Administration to treat opioid use disorder, can be ...

Buprenorphine, an evidence-based treatment for opioid use disorder, is currently underprescribed because of concerns that it can cause "precipitated withdrawal," in which the first dose causes sudden, ...

A seven-day, extended-release version of buprenorphine — a treatment for opioid use disorder (OUD) that can reduce opioid use and overdose deaths — is safe and effective for people with OUD ...

Researchers from Yale School of Medicine have observed that overlapping buprenorphine therapy with long-term opioid therapy may help to avoid significant symptoms of opioid withdrawal in outpatients ...

A woman reaching for a prescription bottle in a medicine cabinet Researchers deployed a survey to individuals who had received treatment for opioid use disorder to assess their use of buprenorphine.

CINCINNATI — The main idea of a program, introduced here last week, to provide medication for inmates who experience opioid withdrawal is to keep them from dying. Hamilton County jail in Cincinnati ...

Buprenorphine is a prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat opioid dependence in adults. Opioid dependence is also called opioid use disorder (OUD), ...

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...

Response to buprenorphine among emergency department (ED) patients using fentanyl was similar to that in patients using other opioids, based on data from nearly 900 individuals. California emergency ...

A study of two opioids used to wean babies born in withdrawal from drugs their mothers have taken shows that buprenorphine is superior to methadone in reducing duration of treatment and length of ...